| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Chief Commercial Officer | Chief Commercial Officer
1 company
Heerma Peter serves as an EVP, Chief Commercial Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 35 sells. Those positions are worth an estimated $7.6M at current prices.
Historically, Heerma Peter's trades have earned a middling insider score of 53/100 across 21 rated trades. Over a 12-month horizon, 31.3% of those trades were profitable, with an average 12-month return of -26.6%.
The biggest single holding is TVTX (~$7.6M) as EVP, Chief Commercial Officer. The recent filings there lean toward selling, a net 359,908 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 3,058 | $24.77 | $75,746.05 | -4.8% | +22.7% | +4.3% | |
| Aug 17, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,407 | $17.12 | $24,086.01 | -2.2% | +48.9% | +40.8% | |
| Feb 8, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 2,250 | $31.50 | $70,863.75 | -3.7% | - | - | |
| Feb 3, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,126 | $29.83 | $33,588.58 | -1.9% | - | - | |
| Oct 5, 2020 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 4,376 | $19.13 | $83,691.00 | -9.4% | - | - |